menu
/CELLULAR &
GENE THERAPY
PRODUCTS
Welcome to Onni Biotechnologies Oy, where cutting-edge research meets a forward-looking perspective on cancer treatment
Since 2022
Future of medicine
/what are we
WORKing on?
Projects
  • 01 /

    A novel approach to analyze TNF family members in the serum of patients diagnosed with gastrointestinal stromal tumors, with the primary objective of refining diagnostic and prognostic assessments

  • 02 /

    Investigation of the interplay of ligands and receptors of TNFSF/TNFRSF families expressed by immune cells (T-cells, NK-cells and T-NK cells) and breast cancer cells, and the possibility to regulate these interactions for therapeutic applications

  • 03 /

    Development of a new approach to the analysis of TNF family members in serum and synovium of patients with rheumatoid arthritis for diagnostic and prognostic purposes

  • 04 /

    Development of novel cancer treatments utilizing engineered natural killer cells

/ABOUT
the COMPANY
Our story
/Onni Biotechnologies Oy
We began our journey in 2001. Researchers at our laboratory began to work on developing novel techniques for the isolation and various modifications of human immune cells.
/LET’S TALK
Have a question?
This website uses cookies to ensure you get the best experience
OK